Global Immunotherapy Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Immunotherapy

• 1.1 Definition of Immunotherapy
• 1.2 Immunotherapy Segment by Type
  • 1.2.1 Global Immunotherapy Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Monoclonal Antibodies
  • 1.2.3 Therapeutic Vaccines
  • 1.2.4 Checkpoint Inhibitors
  • 1.2.5 Non-Specific Immunotherapy
• 1.3 Immunotherapy Segment by Applications
  • 1.3.1 Global Immunotherapy Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Inflammation
  • 1.3.4 Central Nervous System
  • 1.3.5 Others
• 1.4 Global Immunotherapy Overall Market
  • 1.4.1 Global Immunotherapy Revenue (2014-2025)
  • 1.4.2 Global Immunotherapy Production (2014-2025)
  • 1.4.3 North America Immunotherapy Status and Prospect (2014-2025)
  • 1.4.4 Europe Immunotherapy Status and Prospect (2014-2025)
  • 1.4.5 China Immunotherapy Status and Prospect (2014-2025)
  • 1.4.6 Japan Immunotherapy Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Immunotherapy Status and Prospect (2014-2025)
  • 1.4.8 India Immunotherapy Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Immunotherapy
• 2.3 Manufacturing Process Analysis of Immunotherapy
• 2.4 Industry Chain Structure of Immunotherapy

3 Development and Manufacturing Plants Analysis of Immunotherapy

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Immunotherapy Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Immunotherapy
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Immunotherapy Production and Capacity Analysis
• 4.2 Immunotherapy Revenue Analysis
• 4.3 Immunotherapy Price Analysis
• 4.4 Market Concentration Degree

5 Immunotherapy Regional Market Analysis

• 5.1 Immunotherapy Production by Regions
  • 5.1.1 Global Immunotherapy Production by Regions
  • 5.1.2 Global Immunotherapy Revenue by Regions
• 5.2 Immunotherapy Consumption by Regions
• 5.3 North America Immunotherapy Market Analysis
  • 5.3.1 North America Immunotherapy Production
  • 5.3.2 North America Immunotherapy Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Immunotherapy Import and Export
• 5.4 Europe Immunotherapy Market Analysis
  • 5.4.1 Europe Immunotherapy Production
  • 5.4.2 Europe Immunotherapy Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Immunotherapy Import and Export
• 5.5 China Immunotherapy Market Analysis
  • 5.5.1 China Immunotherapy Production
  • 5.5.2 China Immunotherapy Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Immunotherapy Import and Export
• 5.6 Japan Immunotherapy Market Analysis
  • 5.6.1 Japan Immunotherapy Production
  • 5.6.2 Japan Immunotherapy Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Immunotherapy Import and Export
• 5.7 Southeast Asia Immunotherapy Market Analysis
  • 5.7.1 Southeast Asia Immunotherapy Production
  • 5.7.2 Southeast Asia Immunotherapy Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Immunotherapy Import and Export
• 5.8 India Immunotherapy Market Analysis
  • 5.8.1 India Immunotherapy Production
  • 5.8.2 India Immunotherapy Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Immunotherapy Import and Export

6 Immunotherapy Segment Market Analysis (by Type)

• 6.1 Global Immunotherapy Production by Type
• 6.2 Global Immunotherapy Revenue by Type
• 6.3 Immunotherapy Price by Type

7 Immunotherapy Segment Market Analysis (by Application)

• 7.1 Global Immunotherapy Consumption by Application
• 7.2 Global Immunotherapy Consumption Market Share by Application (2014-2019)

8 Immunotherapy Major Manufacturers Analysis

• 8.1 Abbvie
  • 8.1.1 Abbvie Immunotherapy Production Sites and Area Served
  • 8.1.2 Abbvie Product Introduction, Application and Specification
  • 8.1.3 Abbvie Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Amgen, Inc.
  • 8.2.1 Amgen, Inc. Immunotherapy Production Sites and Area Served
  • 8.2.2 Amgen, Inc. Product Introduction, Application and Specification
  • 8.2.3 Amgen, Inc. Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Biogen
  • 8.3.1 Biogen Immunotherapy Production Sites and Area Served
  • 8.3.2 Biogen Product Introduction, Application and Specification
  • 8.3.3 Biogen Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Bristol-Myers Squibb
  • 8.4.1 Bristol-Myers Squibb Immunotherapy Production Sites and Area Served
  • 8.4.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.4.3 Bristol-Myers Squibb Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Celgene
  • 8.5.1 Celgene Immunotherapy Production Sites and Area Served
  • 8.5.2 Celgene Product Introduction, Application and Specification
  • 8.5.3 Celgene Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Johnson & Johnson
  • 8.6.1 Johnson & Johnson Immunotherapy Production Sites and Area Served
  • 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.6.3 Johnson & Johnson Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Merck
  • 8.7.1 Merck Immunotherapy Production Sites and Area Served
  • 8.7.2 Merck Product Introduction, Application and Specification
  • 8.7.3 Merck Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Novartis
  • 8.8.1 Novartis Immunotherapy Production Sites and Area Served
  • 8.8.2 Novartis Product Introduction, Application and Specification
  • 8.8.3 Novartis Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Pfizer
  • 8.9.1 Pfizer Immunotherapy Production Sites and Area Served
  • 8.9.2 Pfizer Product Introduction, Application and Specification
  • 8.9.3 Pfizer Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Roche
  • 8.10.1 Roche Immunotherapy Production Sites and Area Served
  • 8.10.2 Roche Product Introduction, Application and Specification
  • 8.10.3 Roche Immunotherapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Immunotherapy Market

• 9.1 Global Immunotherapy Market Trend Analysis
  • 9.1.1 Global Immunotherapy Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Immunotherapy Regional Market Trend
  • 9.2.1 North America Immunotherapy Forecast 2019-2025
  • 9.2.2 Europe Immunotherapy Forecast 2019-2025
  • 9.2.3 China Immunotherapy Forecast 2019-2025
  • 9.2.4 Japan Immunotherapy Forecast 2019-2025
  • 9.2.5 Southeast Asia Immunotherapy Forecast 2019-2025
  • 9.2.6 India Immunotherapy Forecast 2019-2025
• 9.3 Immunotherapy Market Trend (Product Type)
• 9.4 Immunotherapy Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Immunotherapy Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List